Skip to content

Effects of a phyisiotherapeutic exercise programme in patients with a combination of COPD and chronic heart failure: the CHEST-study.

Effects of a community-based physical exercise programme in patients with a combination of COPD and chronic heart failure: the CHEST-study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON26228
Enrollment
100
Registered
2009-06-05
Start date
2009-08-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic heart failure and COPD.

Interventions

Patients in the intervention group will participate in a community-based physical exercies programme. In this programme, patients will exercise in small groups under supervision of a community based p

Sponsors

Department of Pulmonary Medicine, Medisch Spectrum Twente Enschede
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age between 40 and 75 years; 2. A clinical diagnosis of COPD defined by the GOLD-criteria stage 2 and 3; 3. A diagnosis of chronic heart failure defined by NYHA class II-III; 4. A left ventricular ejection fraction (LVEF) < 40% measured by echocardiogram; 5. A history of smoking of at least 10 pack-years.

Exclusion criteria

Exclusion criteria: 1. Serious other diseases with a survival rate of less than 1 year; 2. Other diseases which generate symptoms of dyspnoea and/or decreased exercise capacity, or which seriously influence the ability to walk; 3. Participation in a pulmonary or cardiac rehabilitation programme less than 1 year ago.

Design outcomes

Primary

MeasureTime frame
The primary outcome measure is exercise capacity measured with the 6 Minutes Walking Test, and daily activity rate, measured by pedometer.

Secondary

MeasureTime frame
Secondary outcomes are: 1. Health-related quality of life (disease specific: Clinical COPD Questionnaire, Minnesota Living with Heart Failure Questionnaire, and generic: Euroqol 5D, SF-36); 2. Health-related behaviour (European Heart Failure Self-care Behaviour Scale); 3. Self-efficacy (COPD Self-efficacy scale); 4. Exercise capacity measured with the Incremental Shuttle Walk Test.

Contacts

Public ContactM. Zwerink
m.zwerink@ziekenhuis-mst.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)